Published in J Virol on July 01, 2005
Three-dimensional analysis of budding sites and released virus suggests a revised model for HIV-1 morphogenesis. Cell Host Microbe (2008) 1.91
How ubiquitin functions with ESCRTs. Traffic (2011) 1.51
Paramyxovirus assembly and budding: building particles that transmit infections. Int J Biochem Cell Biol (2010) 1.44
The cell biology of HIV-1 and other retroviruses. Retrovirology (2006) 1.21
New insights into HIV assembly and trafficking. Physiology (Bethesda) (2011) 1.18
Cell-based quantification of chronic wasting disease prions. J Virol (2010) 1.13
Cumulative mutations of ubiquitin acceptor sites in human immunodeficiency virus type 1 gag cause a late budding defect. J Virol (2006) 1.11
ALIX is a Lys63-specific polyubiquitin binding protein that functions in retrovirus budding. Dev Cell (2012) 1.01
Macrophage bridging conduit trafficking of HIV-1 through the endoplasmic reticulum and Golgi network. J Proteome Res (2011) 0.97
The role of WWP1-Gag interaction and Gag ubiquitination in assembly and release of human T-cell leukemia virus type 1. J Virol (2007) 0.96
Ubiquitination of the prototype foamy virus envelope glycoprotein leader peptide regulates subviral particle release. J Virol (2005) 0.94
Ubiquitination of human immunodeficiency virus type 1 Gag is highly dependent on Gag membrane association. J Virol (2007) 0.93
Characterization of the human endogenous retrovirus K Gag protein: identification of protease cleavage sites. Retrovirology (2011) 0.93
Highly conserved serine residue 40 in HIV-1 p6 regulates capsid processing and virus core assembly. Retrovirology (2011) 0.90
Functional hierarchy of two L domains in porcine endogenous retrovirus (PERV) that influence release and infectivity. Virology (2008) 0.79
The ubiquitin-conjugating system: multiple roles in viral replication and infection. Cells (2014) 0.79
Role of ubiquitin in parainfluenza virus 5 particle formation. J Virol (2012) 0.78
Glutamic Acid Residues in HIV-1 p6 Regulate Virus Budding and Membrane Association of Gag. Viruses (2016) 0.76
Proteolysis of mature HIV-1 p6 Gag protein by the insulin-degrading enzyme (IDE) regulates virus replication in an Env-dependent manner. PLoS One (2017) 0.75
The matrix protein of human immunodeficiency virus is cleaved and packed into virion cores. Dokl Biol Sci (2006) 0.75
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol (1986) 37.70
Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell (2001) 12.00
HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat Med (2001) 8.38
The protein network of HIV budding. Cell (2003) 7.82
HIV-1 gag proteins: diverse functions in the virus life cycle. Virology (1998) 7.32
Retrovirus budding. Annu Rev Cell Dev Biol (2004) 7.16
p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J Virol (1995) 6.87
AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell (2003) 6.69
Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc Natl Acad Sci U S A (2001) 5.83
Viral late domains. J Virol (2002) 4.51
Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc Natl Acad Sci U S A (2000) 4.31
Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins. Proc Natl Acad Sci U S A (2003) 4.21
A role for ubiquitin ligase recruitment in retrovirus release. Proc Natl Acad Sci U S A (2000) 4.19
Ubiquitin is part of the retrovirus budding machinery. Proc Natl Acad Sci U S A (2000) 3.83
Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging. J Virol (2000) 3.54
Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells. Proc Natl Acad Sci U S A (2001) 3.04
Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies. AIDS Res Hum Retroviruses (1994) 2.47
Ubiquitination of HIV-1 and MuLV Gag. Virology (2000) 2.33
Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity. Proc Natl Acad Sci U S A (1991) 2.28
Functional involvement of a novel Nedd4-like ubiquitin ligase on retrovirus budding. EMBO Rep (2002) 2.22
The Mason-Pfizer monkey virus PPPY and PSAP motifs both contribute to virus release. J Virol (2003) 2.19
Ubiquitin in avian leukosis virus particles. Virology (1990) 2.13
Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4. J Mol Biol (2003) 2.11
Context-dependent effects of L domains and ubiquitination on viral budding. J Virol (2004) 1.92
PPPYVEPTAP motif is the late domain of human T-cell leukemia virus type 1 Gag and mediates its functional interaction with cellular proteins Nedd4 and Tsg101 [corrected]. J Virol (2003) 1.80
Budding of equine infectious anemia virus is insensitive to proteasome inhibitors. J Virol (2002) 1.67
Late assembly domain function can exhibit context dependence and involves ubiquitin residues implicated in endocytosis. J Virol (2002) 1.61
Late assembly motifs of human T-cell leukemia virus type 1 and their relative roles in particle release. J Virol (2004) 1.34
Retroviruses have differing requirements for proteasome function in the budding process. J Virol (2003) 1.34
Lysines close to the Rous sarcoma virus late domain critical for budding. J Virol (2004) 1.16
Ubiquitinylation of the cytosolic domain of a type I membrane protein is not required to initiate its dislocation from the endoplasmic reticulum. J Biol Chem (2003) 1.14
Mutation of the major 5' splice site renders a CMV-driven HIV-1 proviral clone Tat-dependent: connections between transcription and splicing. FEBS Lett (2004) 1.03
Passive and active inclusion of host proteins in human immunodeficiency virus type 1 gag particles during budding at the plasma membrane. J Virol (2004) 1.00
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med (2005) 21.56
The protein network of HIV budding. Cell (2003) 7.82
The stoichiometry of Gag protein in HIV-1. Nat Struct Mol Biol (2004) 4.91
HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor. Cell Host Microbe (2009) 4.36
Structural organization of authentic, mature HIV-1 virions and cores. EMBO J (2003) 4.32
The HIV lipidome: a raft with an unusual composition. Proc Natl Acad Sci U S A (2006) 4.15
HIV-1 assembly, budding, and maturation. Cold Spring Harb Perspect Med (2012) 3.17
The HIV-1 capsid protein C-terminal domain in complex with a virus assembly inhibitor. Nat Struct Mol Biol (2005) 3.07
Role of the clathrin terminal domain in regulating coated pit dynamics revealed by small molecule inhibition. Cell (2011) 2.56
HIV-1 buds predominantly at the plasma membrane of primary human macrophages. PLoS Pathog (2007) 2.44
The mechanism of HIV-1 core assembly: insights from three-dimensional reconstructions of authentic virions. Structure (2006) 2.32
Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative. J Virol (2004) 2.24
A peptide inhibitor of HIV-1 assembly in vitro. Nat Struct Mol Biol (2005) 2.21
The Mason-Pfizer monkey virus PPPY and PSAP motifs both contribute to virus release. J Virol (2003) 2.19
Involvement of clathrin-mediated endocytosis in human immunodeficiency virus type 1 entry. J Virol (2005) 2.12
Gag mutations strongly contribute to HIV-1 resistance to protease inhibitors in highly drug-experienced patients besides compensating for fitness loss. PLoS Pathog (2009) 2.06
Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides. PLoS Biol (2012) 2.03
A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism. PLoS Med (2007) 1.99
Live-cell visualization of dynamics of HIV budding site interactions with an ESCRT component. Nat Cell Biol (2011) 1.96
The human endosomal sorting complex required for transport (ESCRT-I) and its role in HIV-1 budding. J Biol Chem (2004) 1.92
Three-dimensional analysis of budding sites and released virus suggests a revised model for HIV-1 morphogenesis. Cell Host Microbe (2008) 1.91
Sialyllactose in viral membrane gangliosides is a novel molecular recognition pattern for mature dendritic cell capture of HIV-1. PLoS Biol (2012) 1.79
Dynamics of HIV-1 assembly and release. PLoS Pathog (2009) 1.67
CD317/tetherin is enriched in the HIV-1 envelope and downregulated from the plasma membrane upon virus infection. J Virol (2010) 1.63
NEDD4L overexpression rescues the release and infectivity of human immunodeficiency virus type 1 constructs lacking PTAP and YPXL late domains. J Virol (2008) 1.60
Aptamer displacement identifies alternative small-molecule target sites that escape viral resistance. Chem Biol (2007) 1.52
Maturation-dependent HIV-1 surface protein redistribution revealed by fluorescence nanoscopy. Science (2012) 1.50
Double-labelled HIV-1 particles for study of virus-cell interaction. Virology (2006) 1.49
HIV-1 Gag processing intermediates trans-dominantly interfere with HIV-1 infectivity. J Biol Chem (2009) 1.47
The molecular architecture of HIV. J Mol Biol (2011) 1.44
Ultrastructural analysis of ESCRT proteins suggests a role for endosome-associated tubular-vesicular membranes in ESCRT function. Traffic (2006) 1.39
Cryo electron tomography of native HIV-1 budding sites. PLoS Pathog (2010) 1.39
Functional characterization of HIV-1 Nef mutants in the context of viral infection. Virology (2006) 1.36
Structural analysis of HIV-1 maturation using cryo-electron tomography. PLoS Pathog (2010) 1.36
More than one door - Budding of enveloped viruses through cellular membranes. FEBS Lett (2007) 1.35
Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis. J Med Virol (2006) 1.34
Interactions of human retroviruses with the host cell cytoskeleton. Curr Opin Microbiol (2006) 1.26
Super-resolution microscopy reveals specific recruitment of HIV-1 envelope proteins to viral assembly sites dependent on the envelope C-terminal tail. PLoS Pathog (2013) 1.25
Robust RNAi enhancement via human Argonaute-2 overexpression from plasmids, viral vectors and cell lines. Nucleic Acids Res (2013) 1.20
T20-insensitive HIV-1 from naive patients exhibits high viral fitness in a novel dual-color competition assay on primary cells. Virology (2005) 1.11
From nonpeptide toward noncarbon protease inhibitors: metallacarboranes as specific and potent inhibitors of HIV protease. Proc Natl Acad Sci U S A (2005) 1.11
Cumulative mutations of ubiquitin acceptor sites in human immunodeficiency virus type 1 gag cause a late budding defect. J Virol (2006) 1.11
Differential dependence of the infectivity of HIV-1 group O isolates on the cellular protein cyclophilin A. Virology (2002) 1.11
Comparative lipidomics analysis of HIV-1 particles and their producer cell membrane in different cell lines. Cell Microbiol (2013) 1.11
Conserved and variable features of Gag structure and arrangement in immature retrovirus particles. J Virol (2010) 1.09
Role of lipids in virus replication. Cold Spring Harb Perspect Biol (2011) 1.08
Human immunodeficiency virus type 1 Nef protein modulates the lipid composition of virions and host cell membrane microdomains. Retrovirology (2007) 1.08
Probing HIV-1 membrane liquid order by Laurdan staining reveals producer cell-dependent differences. J Biol Chem (2009) 1.07
The late-domain-containing protein p6 is the predominant phosphoprotein of human immunodeficiency virus type 1 particles. J Virol (2002) 1.04
Mutation of the major 5' splice site renders a CMV-driven HIV-1 proviral clone Tat-dependent: connections between transcription and splicing. FEBS Lett (2004) 1.03
Single-molecule coordinate-based analysis of the morphology of HIV-1 assembly sites with near-molecular spatial resolution. Histochem Cell Biol (2012) 1.02
Splicing of human immunodeficiency virus RNA is position-dependent suggesting sequential removal of introns from the 5' end. Nucleic Acids Res (2005) 1.02
Divergent evolution in reverse transcriptase (RT) of HIV-1 group O and M lineages: impact on structure, fitness, and sensitivity to nonnucleoside RT inhibitors. J Virol (2010) 1.01
Molecular characterization of a respiratory syncytial virus outbreak in a hematology unit in Heidelberg, Germany. J Clin Microbiol (2012) 1.00
Architecture and regulation of the HIV-1 assembly and holding compartment in macrophages. J Virol (2011) 1.00
Genotypic and phenotypic analysis of HIV type 1 primary isolates from western Cameroon. AIDS Res Hum Retroviruses (2002) 1.00
Visualizing fusion of pseudotyped HIV-1 particles in real time by live cell microscopy. Retrovirology (2009) 0.97
From experimental setup to bioinformatics: an RNAi screening platform to identify host factors involved in HIV-1 replication. Biotechnol J (2010) 0.96
Design of HIV protease inhibitors based on inorganic polyhedral metallacarboranes. J Med Chem (2009) 0.96
Construction and characterisation of a full-length infectious molecular clone from a fast replicating, X4-tropic HIV-1 CRF02.AG primary isolate. Virology (2003) 0.95
HIV drug resistance pattern among HAART-exposed patients with suboptimal virological response in Ouagadougou, Burkina Faso. J Acquir Immune Defic Syndr (2008) 0.95
Primary T-cells from human CD4/CCR5-transgenic rats support all early steps of HIV-1 replication including integration, but display impaired viral gene expression. Retrovirology (2007) 0.94
A quantitative measure for alterations in the actin cytoskeleton investigated with automated high-throughput microscopy. Cytometry A (2010) 0.94
Ubiquitination of human immunodeficiency virus type 1 Gag is highly dependent on Gag membrane association. J Virol (2007) 0.93
Mutations in HIV-1 gag and pol compensate for the loss of viral fitness caused by a highly mutated protease. Antimicrob Agents Chemother (2012) 0.93
Construction and characterization of an HIV-1 group O infectious molecular clone and analysis of vpr- and nef-negative derivatives. Virology (2004) 0.93
Role of the SP2 domain and its proteolytic cleavage in HIV-1 structural maturation and infectivity. J Virol (2012) 0.92
HIV-1-cellular interactions analyzed by single virus tracing. Eur Biophys J (2008) 0.92
Selective killing of human immunodeficiency virus infected cells by non-nucleoside reverse transcriptase inhibitor-induced activation of HIV protease. Retrovirology (2010) 0.90
Direct and dynamic detection of HIV-1 in living cells. PLoS One (2012) 0.89
Gag-Pol processing during HIV-1 virion maturation: a systems biology approach. PLoS Comput Biol (2013) 0.89
Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina Faso. J Med Virol (2009) 0.89
Nuclear RNAs confined to a reticular compartment between chromosome territories. Exp Cell Res (2005) 0.89
Transport of the intracisternal A-type particle Gag polyprotein to the endoplasmic reticulum is mediated by the signal recognition particle. J Virol (2003) 0.87
Comprehensive mutational analysis reveals p6Gag phosphorylation to be dispensable for HIV-1 morphogenesis and replication. J Virol (2012) 0.87
Multimerizable HIV Gag derivative binds to the liquid-disordered phase in model membranes. Cell Microbiol (2012) 0.87
The cellular protein lyric interacts with HIV-1 Gag. J Virol (2011) 0.84
Computational identification of novel amino-acid interactions in HIV Gag via correlated evolution. PLoS One (2012) 0.83
An expanded model of HIV cell entry phenotype based on multi-parameter single-cell data. Retrovirology (2012) 0.82
Selection of potent non-toxic inhibitory sequences from a randomized HIV-1 specific lentiviral short hairpin RNA library. PLoS One (2010) 0.81
Immune Reconstitution During the First Year of Antiretroviral Therapy of HIV-1-Infected Adults in Rural Burkina Faso. Open AIDS J (2012) 0.81
The major 5' end of HIV type 1 RNA corresponds to G456. AIDS Res Hum Retroviruses (2007) 0.81
Acetylation of the foamy virus transactivator Tas by PCAF augments promoter-binding affinity and virus transcription. J Gen Virol (2007) 0.80
Antiviral strategies. Handb Exp Pharmacol (2009) 0.80
Antiviral strategies. Preface. Handb Exp Pharmacol (2009) 0.79
Constitutive activation and accelerated maturation of peripheral blood T cells in healthy adults in Burkina Faso compared to Germany: the case of malaria? Eur J Med Res (2011) 0.79
The murine endogenous retrovirus MIA14 encodes an active aspartic proteinase that is functionally similar to proteinases from D-type retroviruses. Arch Biochem Biophys (2002) 0.78
Mutations in multiple domains of Gag drive the emergence of in vitro resistance to the phosphonate-containing HIV-1 protease inhibitor GS-8374. J Virol (2012) 0.78
Cross-clade recognition of HIV-1 CAp24 by CD4+ T cells in HIV-1-infected individuals in Burkina Faso and Germany. Open AIDS J (2009) 0.78
Genotypic resistance testing in HIV by arrayed primer extension. Anal Bioanal Chem (2008) 0.76
Viruses: membranes in disguise--editorial on the special issue reporting on the priority program 1175 of the Deutsche Forschungsgemeinschaft (German Research Foundation): 'Dynamics of cellular membranes and their exploitation by viruses'. Cell Microbiol (2013) 0.75
HIV: epidemiology and strategies for therapy and vaccination. Intervirology (2002) 0.75
Delayed detection of cytomegalovirus-specific T-helper cells in a preterm infant following intrauterine exposure to tacrolimus. Clin Lab (2012) 0.75